Bristol-Myers Squibb has won FDA approval for the first LAG-3 inhibitor drug ahead of its rivals in cancer immunotherapy, including Merck & Co. The US regulator cleared BMS' LAG-3 drug relatlimab as a ...
Goodbye for 2025 - here are some great reads for the festive period It's been a year in which market swings and political zigzagging on both sides of the Atlantic had tangible impacts on your finances ...
LAG provides a logical rule-based reasoner and explanation engine backend for LLM-based AI applications. It continues the sequence of innovations: LLM -> RAG -> PAL -> LAG This repository explains the ...
The AWS SDK for Java enables Java developers to easily work with Amazon Web Services and build scalable solutions with Amazon S3, Amazon DynamoDB, Amazon Glacier, and more. See the AWS SDK for Java ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results